Functional metabolomics uncovers metabolic alterations associated to severe oxidative stress in MCF7 breast cancer cells exposed to ascididemin

Marine Drugs

Volumn 11, Issue 10, 2013, Pages 3846-3860

  Morvan, Daniel ^a,b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CENTRE JEAN PERRIN   (France)

Author keywords

Ascididemin; Biomarkers; Breast adenocarcinoma cells; Inflammation; Metabolic pathway discovery; Metabolomics; Oxidative stress

Indexed keywords

ACONITATE HYDRATASE; ALANINE; ARGININE; ASCIDIDEMIN; ASPARAGINE; ASPARTIC ACID; CITICOLINE; CITRIC ACID; CREATINE; GLUCONIC ACID; GLUTAMIC ACID; GLUTAMINE; GLYCEROPHOSPHOETHANOLAMINE; GLYCEROPHOSPHORYLCHOLINE; GLYCINE; HOMOCYSTEINE; HYPOTAURINE; LACTIC ACID; LYSINE; METHIONINE; N ACETYLASPARTIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE; POLYAMINE; POLYUNSATURATED FATTY ACID; PROLINE; TAURINE; TRICARBOXYLIC ACID;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; DISEASE SEVERITY; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DISORDERS OF CARBOHYDRATE METABOLISM; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DOWN REGULATION; GLYCOLYSIS; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; METABOLIC DISORDER; METABOLOMICS; OXIDATIVE STRESS; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS;

ALKALOIDS; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; MCF-7 CELLS; METABOLOME; METABOLOMICS; OXIDATIVE STRESS; PHENANTHROLINES; QUINOLINES;

EID: 84887069167     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md11103846     Document Type: Article

References (20)

1. Clayton, T.A.; Lindon, J.C.; Cloarec, O.; Antti, H.; Charuel, C.; Hanton, G.; Provost, J.P.; Le Net, J.L.; Baker, D.; Walley, R.J.; Everett, J.R.; Nicholson, J.K. Pharmaco-metabonomic phenotyping and personalized drug treatment. Nature 2006, 440, 1073-1077.
2. Griffin, J.L.; Shockcor, J.P. Metabolic profiles of cancer cells. Nat. Rev. Cancer 2004, 4, 551-561. (Pubitemid 38868624)
3. Morvan, D.; Demidem, A. Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways. Cancer Res. 2007, 67, 2150-2159. (Pubitemid 46424234)
4. Bayet-Robert, M.; Morvan, D. Metabolomics reveals metabolic targets and biphasic responses in breast cancer cells treated by curcumin alone and in association with docetaxel. PLoS One 2013, 8, e57971.
5. Bayet-Robert, M.; Morvan, D.; Chollet, P.; Barthomeuf, C. Pharmacometabolomics of docetaxel-treated human MCF7 breast cancer cells provides evidence of varying cellular responses at high and low doses. Breast Cancer Res. Treat. 2010, 120, 613-626.
6. Dirsch, V.M.; Kirschke, S.O.; Estermeier, M.; Steffan, B.; Vollmar, A.M. Apoptosis signaling triggered by the marine alkaloid ascididemin is routed via caspase-2 and JNK to mitochondria. Oncogene 2004, 23, 1586-1593. (Pubitemid 38406521)
7. Dassonneville, L.; Wattez, N.; Baldeyrou, B.; Mahieu, C.; Lansiaux, A.; Banaigs, B.; Bonnard, I.; Bailly, C. Inhibition of topoisomerase II by the marine alkaloid ascididemin and induction of apoptosis in leukemia cells. Biochem. Pharmacol. 2000, 60, 527-537. (Pubitemid 30389619)
8. Matsumoto, S.S.; Biggs, J.; Copp, B.R.; Holden, J.A.; Barrows, L.R. Mechanism of ascididemin-induced cytotoxicity. Chem. Res. Toxicol. 2003, 16, 113-122. (Pubitemid 36245860)
9. Marshall, K.M.; Matsumoto, S.S.; Holden, J.A.; Concepcion, G.P.; Tasdemir, D.; Ireland, C.M.; Barrows, L.R. The anti-neoplastic and novel topoisomerase II-mediated cytotoxicity of neoamphimedine, a marine pyridoacridine. Biochem. Pharmacol. 2003, 66, 447-458. (Pubitemid 36937030)
10. BMRB Biological Magnetic Resonance Databank. Available online: http://www.bmrd.wisc.edu (accessed on 18 July 2013).
11. HMDB Human Metabolome Database. Available online: http://www.hmdb.ca (accessed on 18 July 2013).
12. Bayet-Robert, M.; Lim, S.; Barthomeuf, C.; Morvan, D. Biochemical disorders induced by cytotoxic marine natural products in breast cancer cells as revealed by proton NMR spectroscopy-based metabolomics. Biochem. Pharmacol. 2010, 80, 1170-1179.
13. Baburina, I.; Jackowski, S. Cellular responses to excess phospholipid. J. Biol. Chem. 1999, 274, 9400-9408.
14. Kuda, O.; Jenkins, C.M.; Skinner, J.R.; Moon, S.H.; Su, X.; Gross, R.W.; Abumrad, N.A. CD36 protein is involved in store-operated calcium flux, phospholipase A2 activation, and production of prostaglandin E2. J. Biol. Chem. 2011, 286, 17785-17795.
15. Nulton-Persson, A.C.; Szweda, L.I. Modulation of mitochondrial function by hydrogen peroxide. J. Biol. Chem. 2001, 276, 23357-23361.
16. Droge, W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82, 47-95. (Pubitemid 34654215)
17. Machida, K.; Ohta, Y.; Osada, H. Suppression of apoptosis by cyclophilin D via stabilization of hexokinase II mitochondrial binding in cancer cells. J. Biol. Chem. 2006, 281, 14314-14320. (Pubitemid 43848360)
18. Ramanathan, A.; Wang, C.; Schreiber, S.L. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc. Natl. Acad. Sci. USA 2005, 102, 5992-5997. (Pubitemid 40594243)
19. Tuttle, S.W.; Maity, A.; Oprysko, P.R.; Kachur, A.V.; Ayene, I.S.; Biaglow, J.E.; Koch, C.J. Detection of reactive oxygen species via endogenous oxidative pentose phosphate cycle activity in response to oxygen concentration: Implications for the mechanism of HIF-1alpha stabilization under moderate hypoxia. J. Biol. Chem. 2007, 282, 36790-36796.
20. Hininger, I.; Chollat-Namy, A.; Sauvaigo, S.; Osman, M.; Faure, H.; Cadet, J.; Favier, A.; Roussel, A.M. Assessment of DNA damage by comet assay on frozen total blood: Method and evaluation in smokers and non-smokers. Mutat. Res. 2004, 558, 75-80. (Pubitemid 38229636)